Surrozen, Inc.

NasdaqCM:SRZN Stock Report

Market Cap: US$346.2m

Surrozen Management

Management criteria checks 3/4

Surrozen's CEO is Craig Parker, appointed in Mar 2018, has a tenure of 8.17 years. total yearly compensation is $2.82M, comprised of 22.3% salary and 77.7% bonuses, including company stock and options. directly owns 0.14% of the company’s shares, worth $498.92K. The average tenure of the management team and the board of directors is 4.3 years and 5.1 years respectively.

Key information

Craig Parker

Chief executive officer

US$2.8m

Total compensation

CEO salary percentage22.35%
CEO tenure8.2yrs
CEO ownership0.1%
Management average tenure4.3yrs
Board average tenure5.1yrs

Recent management updates

Recent updates

Analysis Article • Jan 06

Surrozen (NASDAQ:SRZN) Is In A Good Position To Deliver On Growth Plans

Just because a business does not make any money, does not mean that the stock will go down. For example, although...
Analysis Article • Jun 25

Companies Like Surrozen (NASDAQ:SRZN) Are In A Position To Invest In Growth

Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...
Analysis Article • Dec 04

Companies Like Surrozen (NASDAQ:SRZN) Could Be Quite Risky

Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...
Analysis Article • Aug 21

Here's Why We're A Bit Worried About Surrozen's (NASDAQ:SRZN) Cash Burn Situation

Just because a business does not make any money, does not mean that the stock will go down. For example, although...
Analysis Article • Jan 03

Will Surrozen (NASDAQ:SRZN) Spend Its Cash Wisely?

We can readily understand why investors are attracted to unprofitable companies. For example, biotech and mining...
Analysis Article • Jun 19

Will Surrozen (NASDAQ:SRZN) Spend Its Cash Wisely?

Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...
Analysis Article • Feb 12

Here's Why Surrozen (NASDAQ:SRZN) Must Use Its Cash Wisely

We can readily understand why investors are attracted to unprofitable companies. For example, biotech and mining...
Seeking Alpha • Oct 06

Surrozen stock rises ~13% premarket on licensing deal with Boehringer Ingelheim

Surrozen (NASDAQ:SRZN) on Thursday said it had entered into a collaboration and licensing agreement with German pharmaceutical firm Boehringer Ingelheim for its antibody SZN-413 for the treatment of eye diseases. SRZN stock +12.5% to $2.43 in premarket trading. This is the first partnership that SRZN had entered for one of its compounds, the company said in a statement. As per the terms of the deal, SRZN will get an upfront payment of $12.5M from Boehringer. Boehringer will get an exclusive, worldwide license to develop SZN-413. SRZN will be eligible to get up to $586.5M in milestone payments and royalties on sales.
Seeking Alpha • Aug 11

Surrozen GAAP EPS of -$0.40 beats by $0.06

Surrozen press release (NASDAQ:SRZN): Q2 GAAP EPS of -$0.40 beats by $0.06. Cash, cash equivalents and marketable securities for the Q2 were $92.7 million
Seeking Alpha • Oct 14

Surrozen CEO Craig Parker - Biotechs Can Never Be Too Well Capitalized (Video)

Surrozen is pioneering targeted therapeutics that selectively activate the Wnt pathway for tissue repair and regeneration. CEO Craig Parker, an industry veteran, joined us to discuss why there's no such thing as being too well capitalized in the biotech industry. 'We were really excited to complete a SPAC PIPE transaction that funds us through some of these Phase IB milestones in 2024.'

CEO Compensation Analysis

How has Craig Parker's remuneration changed compared to Surrozen's earnings?
DateTotal CompensationSalaryCompany Earnings
Mar 31 2026n/an/a

-US$343m

Dec 31 2025US$3mUS$630k

-US$242m

Sep 30 2025n/an/a

-US$87m

Jun 30 2025n/an/a

-US$17m

Mar 31 2025n/an/a

-US$71m

Dec 31 2024US$2mUS$605k

-US$64m

Sep 30 2024n/an/a

-US$44m

Jun 30 2024n/an/a

-US$53m

Mar 31 2024n/an/a

-US$38m

Dec 31 2023US$1mUS$580k

-US$43m

Sep 30 2023n/an/a

-US$35m

Jun 30 2023n/an/a

-US$38m

Mar 31 2023n/an/a

-US$42m

Dec 31 2022US$2mUS$558k

-US$36m

Sep 30 2022n/an/a

-US$50m

Jun 30 2022n/an/a

-US$51m

Mar 31 2022n/an/a

-US$50m

Dec 31 2021US$4mUS$496k

-US$55m

Sep 30 2021n/an/a

-US$51m

Jun 30 2021n/an/a

-US$45m

Mar 31 2021n/an/a

-US$39m

Dec 31 2020US$554kUS$441k

-US$33m

Compensation vs Market: Craig's total compensation ($USD2.82M) is about average for companies of similar size in the US market ($USD2.57M).

Compensation vs Earnings: Craig's compensation has increased whilst the company is unprofitable.

CEO

Craig Parker (63 yo)

8.2yrs
Tenure
US$2,819,017
Compensation

Mr. Craig C. Parker, MBA, is Director of Synthekine, Inc. Mr. Parker serves as Chief Executive Officer and President since March 2018 and Director at Surrozen, Inc., since April 2018. He serves as Director...

Leadership Team

NamePositionTenureCompensationOwnership
Craig Parker
CEO, President & Director8.2yrsUS$2.82m0.14%
$ 498.9k
Charles Williams
COO & Corporate Secretary3.3yrsUS$1.52m0.14%
$ 499.4k
Yang Li
Executive Vice President of Research5.3yrsUS$1.29m0.16%
$ 540.1k
K. Christopher Garcia
Co-Founder & Member of Scientific Advisory Boardno datano datano data
Roeland Nusse
Co-Founder & Member of Scientific Advisory Boardno datano datano data
Calvin Kuo
Co-Founder & Member of Scientific Advisorno datano datano data
Andrew Maleki
Chief Financial Officerless than a yearno datano data
Daniel Chao
VP & Head of Clinical Developmentno datano datano data
Michael Lauw
Senior Vice President of Development Operationsno datano datano data
Esther Jhun
Controllerno datano datano data
4.3yrs
Average Tenure
56yo
Average Age

Experienced Management: SRZN's management team is considered experienced (4.3 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Craig Parker
CEO, President & Director8.1yrsUS$2.82m0.14%
$ 498.9k
K. Christopher Garcia
Co-Founder & Member of Scientific Advisory Boardno datano datano data
Roeland Nusse
Co-Founder & Member of Scientific Advisory Boardno datano datano data
Calvin Kuo
Co-Founder & Member of Scientific Advisorno datano datano data
Eric Bjerkholt
Independent Director3.1yrsUS$49.17k0%
$ 0
Harold Varmus
Member of Scientific Advisorsno dataUS$24.00kno data
Mace Rothenberg
Independent Director5.1yrsUS$52.25k0.020%
$ 70.6k
Christopher Chai
Independent Director5.1yrsUS$60.67k0.020%
$ 70.6k
Mary Haak-Frendscho
Independent Director5.2yrsUS$51.67k0.020%
$ 70.6k
Tim Kutzkey
Independent Director1.2yrsUS$50.13k0%
$ 0
Anna Berkenblit
Independent Director7.8yrsUS$53.25k0.020%
$ 70.6k
David Woodhouse
Independent Chairman of the Board5.7yrsUS$79.17k0.020%
$ 70.6k
5.1yrs
Average Tenure
63yo
Average Age

Experienced Board: SRZN's board of directors are considered experienced (5.1 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/05/14 12:59
End of Day Share Price 2026/05/14 00:00
Earnings2026/03/31
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Surrozen, Inc. is covered by 8 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Tazeen AhmadBofA Global Research
Steven SeedhouseCantor Fitzgerald & Co.
Yatin SunejaGuggenheim Securities, LLC